Cancer Vaccines Market Anticipates Impressive Growth Trajectory at a CAGR of 36% During the Forecast Period (2026-2036) | DelveInsight
Why now
Thesis: Cancer-vaccine growth forecast highlights pipeline optionality for large pharma.
Catalyst to watch: Clinical trial readouts.
Main risk: Pipeline failures.
Why it matters
Forecast cancer-vaccine growth highlights pipeline optionality for large pharma oncology players.
Details
The growth of the cancer vaccine market is expected to be mainly driven by increasing incidence, rising awareness and access to treatment, and the emergence of novel therapies such as OSE2101 (OSE Immunotherapeutic), Intismeran autogene (Merck/Moderna Therapeutics), CYLEMBIO (IO102-IO103)...
Sources
- prnewswire · 2026-09-21 14:31 UTC